These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25355040)

  • 1. Investigating gender disparities in the profile and treatment outcomes of tuberculosis in Ebonyi state, Nigeria.
    Oshi SN; Alobu I; Ukwaja KN; Oshi DC
    Epidemiol Infect; 2015 Apr; 143(5):932-42. PubMed ID: 25355040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
    Adane K; Spigt M; Dinant GJ
    BMC Pulm Med; 2018 Feb; 18(1):37. PubMed ID: 29463234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study on tuberculosis treatment outcomes at Jinka General Hospital, southern Ethiopia.
    Wondale B; Medihn G; Teklu T; Mersha W; Tamirat M; Ameni G
    BMC Res Notes; 2017 Dec; 10(1):680. PubMed ID: 29202880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six- vs. eight-month anti-tuberculosis regimen for pulmonary tuberculosis under programme conditions.
    Ukwaja KN; Oshi SN; Alobu I; Oshi DC
    Int J Tuberc Lung Dis; 2015 Mar; 19(3):295-301, i-vii. PubMed ID: 25686137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
    Park S; Jo KW; Lee SD; Kim WS; Shim TS
    Respir Med; 2017 Oct; 131():43-48. PubMed ID: 28947041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
    Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R
    BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009.
    Gegia M; Cohen T; Kalandadze I; Vashakidze L; Furin J
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):812-6. PubMed ID: 22507372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of rifampicin resistance tuberculosis among HIV/TB coinfected patients in Benue State, Nigeria.
    Ejeh FE; Undiandeye A; Okon K; Moshood KH
    Pan Afr Med J; 2021; 38():203. PubMed ID: 33995809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of rural residence and HIV infection on poor tuberculosis treatment outcomes in a large urban hospital: a retrospective cohort analysis.
    Adamu AL; Aliyu MH; Galadanci NA; Musa BM; Lawan UM; Bashir U; Abubakar I
    Int J Equity Health; 2018 Jan; 17(1):4. PubMed ID: 29310659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
    Ishiwada N; Tokunaga O; Nagasawa K; Ichimoto K; Kinoshita K; Hishiki H; Kohno Y
    Tohoku J Exp Med; 2013 Mar; 229(3):221-5. PubMed ID: 23470647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
    Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
    BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus infection in children with tuberculosis in Santo Domingo, Dominican Republic: prevalence, clinical findings, and response to antituberculosis treatment.
    Espinal MA; Reingold AL; Pérez G; Camilo E; Soto S; Cruz E; Matos N; Gonzalez G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Oct; 13(2):155-9. PubMed ID: 8862280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome of tuberculosis treatment regimens in Kandahar, Afghanistan.
    Rahimi BA; Rahimy N; Ahmadi Q; Hayat MS; Wasiq AW
    Indian J Tuberc; 2020 Jan; 67(1):87-93. PubMed ID: 32192624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of tuberculosis treatment success among HIV-TB co-infected patients attending major tuberculosis treatment sites in Abeokuta, Ogun State, Nigeria.
    Akanbi K; Ajayi I; Fayemiwo S; Gidado S; Oladimeji A; Nsubuga P
    Pan Afr Med J; 2019; 32(Suppl 1):7. PubMed ID: 30984328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis.
    Tabarsi P; Baghaei P; Hemmati N; Mirsaeidi M; Kazempour M; Mansouri D; Masjedi MR
    East Mediterr Health J; 2009; 15(6):1346-50. PubMed ID: 20218123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile and treatment outcomes of tuberculosis in the elderly in southeastern Nigeria, 2011-2012.
    Oshi DC; Oshi SN; Alobu I; Ukwaja KN
    PLoS One; 2014; 9(11):e111910. PubMed ID: 25369001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.
    Chirehwa MT; McIlleron H; Rustomjee R; Mthiyane T; Onyebujoh P; Smith P; Denti P
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
    Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z
    Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.